Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Mads Krogsgaard Thomsen
Age : 60
Public asset : 15,111,261 USD
Country of residence : Unknown
Linked companies : Novo Nordisk A/S - BB Biotech AG

Biography of Mads Krogsgaard Thomsen 
Currently, Mads Krogsgaard Thomsen occupies the position of Chairman for Steno Diabetes Center An and Chief Science Officer & Executive Vice President at Novo Nordisk A. Dr. Thomsen is also on the board of BB Biotech AG and Symphogen An and Chairman of the University of Copenhagen. Dr. Thomsen previously held the position of President at The Danish Academy of Technical Sciences. Dr. Thomsen received a doctorate from the University of Copenhagen.


Current positions of Mads Krogsgaard Thomsen 
Mads Krogsgaard Thomsen : Personal Network 
Most Read News 
07/12ELON MUSK : Musk tells SolarCity trial that Tesla would 'die' if he wasn't CEO
RE
07/15JAMIE DIMON : Analysis-JPMorgan hoards cash as Dimon expects rates to rise
RE
07/13RICHARD BRANSON : Virgin Galactic acknowledges Branson's pre-launch bike ride never happened
RE
07/20JEFF BEZOS : billionaire Bezos has successful suborbital jaunt
RE
07/13ELON MUSK : Musk defends timing of Tesla's $2.6 billion deal for SolarCity
RE
07/09ELON MUSK : Who controls Tesla?
RE
07/13BRUNELLO CUCINELLI : Italian luxury group Cucinelli raises 2021 sales forecast again
RE
07/22RYAN COHEN : Flush from Reddit rally, GameStop plots store revival
RE
07/18ALEXANDER NOVAK : Novak says Russia to raise oil output in H2
RE
07/20WILLIAM ACKMAN : Analysis-SPAC u-turn mars Ackman's hedge fund pivot
RE
More news


© 2021 People and Ownership :   
Mads Krogsgaard Thomsen : Connections 


Latest news about Mads Krogsgaard Thomsen 
03/18DGAP-NEWS : L'Assemblea generale di BB Biotech AG approva tutte le proposte e autorizza il pagamento di un dividendo di CHF 3.60
DJ
03/18PRESS RELEASE : Shareholders at BB Biotech AG's AGM vote in favor of all proposals and approve the dividend of CHF 3.60 per share
DJ
2020NOVO NORDISK A/S : Files For EU Approval of Obesity Drug
DJ
2020NOVO NORDISK A/S : to Test Semaglutide in Late-Stage Alzheimer's Disease Study
MT
2020NOVO NORDISK A/S : Files FDA New Drug Application for Obesity Drug
DJ
2020NOVO NORDISK A/S : to boost pill-form diabetic drugs with $1.8 billion deal
RE
More news